Furthermore, IL-5 and the IL-5 receptor α chain (IL-5Rα) are potential EoE treatment targets because their signaling is important in eosinophilic accumulation and chronic eosinophil infiltration, which leads to tissue fibrosis [19]. The gene discussed is IL5; the disease is eosinophilic esophagitis.